CAT
Caterpillar Inc.
CAT's fundamentals are strong, but it looks expensive: trading at 24x earnings, above its usual 18x. Analysts expect strong earnings growth, though they disagree widely on how much.
RR
Richtech Robotics Inc. Class B Common Stock
There isn't enough reported data to score RR yet.
CAT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Strong |
CAT's revenue, profitability, cash flow and balance sheet are all currently healthy.
RR Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Stable |
RR's revenue is currently healthy, and its balance sheet is stable, but its profitability and cash flow are weak.
CAT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 15x | $380 | -37% |
| Fair | 18x | $461 | -24% |
| Forward | 20x | $605 | — |
| Current | 24x | $605 | — |
| Expensive | 33x | $840 | +39% |
Historical ranges are pointers, not guarantees.
CAT's PE is in its expensive range at 24x. If earnings grow as analysts expect, today's price would be 20x next year's earnings, in its fair range.
RR PE Valuation
RR has no meaningful PE right now: it lost money over the past year.
CAT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Low |
Analysts expect earnings and revenue growth for CAT, with profitability improving. However, they disagree widely on these estimates.
RR Forward outlook
There aren't enough analyst estimates for RR to show an outlook.
CAT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $29.73 | +17% |
| Q3 2026 | $25.48 | +31% |
| Q2 2026 | $23.23 | +18% |
| Q1 2026 | $20.08 | -2% |
| Q4 2025 | $18.81 | -15% |
| Q3 2025 | $19.46 | -9.7% |
| Q2 2025 | $19.64 | -10% |
| Q1 2025 | $20.50 | -7.4% |
| Q4 2024 | $22.05 | +9.6% |
CAT has the edge over RR on earnings quality, reporting a profit while its opponent remains loss making.
RR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.13 | +$0.04 |
| Q1 2026 | -$0.13 | +$0.02 |
| Q4 2025 | -$0.18 | -$0.06 |
| Q3 2025 | -$0.17 | -$0.05 |
| Q2 2025 | -$0.17 | -$0.12 |
| Q1 2025 | -$0.15 | -$0.11 |
| Q4 2024 | -$0.12 | -$0.09 |
| Q3 2024 | -$0.12 | -$0.11 |
RR lost $0.13 per share over the past year, a smaller loss than the year before.
CAT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.7B | +17% |
| Q2 2026 | $20.5B | +24% |
| Q1 2026 | $17.4B | +22% |
| Q4 2025 | $19.1B | +18% |
| Q3 2025 | $17.6B | +9.5% |
| Q2 2025 | $16.6B | -0.7% |
| Q1 2025 | $14.2B | -9.8% |
| Q4 2024 | $16.2B | -5% |
CAT has the edge over RR on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +3.1 points |
| Q2 2026 | 21% | +3.6 points |
| Q1 2026 | 18% | -0.4 points |
| Q4 2025 | 14% | -4.1 points |
| Q3 2025 | 17% | -2.2 points |
| Q2 2025 | 17% | -3.6 points |
| Q1 2025 | 18% | -4.2 points |
| Q4 2024 | 18% | -0.3 points |
CAT has the edge over RR on profitability, with a higher operating margin.
RR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $1.4M | +17% |
| Q1 2026 | $1.5M | +29% |
| Q4 2025 | $1.1M | -15% |
| Q3 2025 | $1.4M | +175% |
| Q2 2025 | $1.2M | -18% |
| Q1 2025 | $1.2M | +0.2% |
| Q4 2024 | $1.3M | +14% |
| Q3 2024 | $525K | -90% |
RR's revenue is recovering but still below its 2023 peak: $1M last quarter, up 17% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -966% | -583 points |
| Q1 2026 | -335% | +88 points |
| Q4 2025 | -1155% | -845 points |
| Q3 2025 | -443% | +123 points |
| Q2 2025 | -383% | -321 points |
| Q1 2025 | -423% | -342 points |
| Q4 2024 | -310% | -106 points |
| Q3 2024 | -566% | -617 points |
RR's operating margin was −966% last quarter, down 583 points from the same quarter a year ago, near the bottom of its range since 2021.
CAT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.7B | +19% |
| Q2 2026 | $3.8B | +47% |
| Q1 2026 | $1.1B | +97% |
| Q4 2025 | $2.7B | +0.1% |
| Q3 2025 | $3.1B | -1.5% |
| Q2 2025 | $2.6B | -4.2% |
| Q1 2025 | $579M | -63% |
| Q4 2024 | $2.7B | -22% |
CAT has the edge over RR on cash generation, producing positive trailing cash flow while its opponent burns cash.
RR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$23M | -$15.4M |
| Q1 2026 | -$662K | +$3.9M |
| Q4 2025 | -$1.7M | +$2M |
| Q2 2025 | -$7.6M | -1904% |
| Q1 2025 | -$4.5M | -$3.2M |
| Q4 2024 | -$3.7M | -$2.5M |
| Q2 2024 | $422K | +$1M |
| Q1 2024 | -$1.3M | -$901K |
RR has burned cash in almost every quarter: −$29M over the past year, against −$15M the year before.
CAT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.5x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.3x | Net Cash |
| Q4 2025 | 2.0x | Healthy |
| Q3 2025 | -0.6x | Net Cash |
| Q2 2025 | -0.4x | Net Cash |
| Q1 2025 | -0.3x | Net Cash |
| Q4 2024 | 1.6x | Healthy |
CAT has more cash than debt.
RR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2023 | 2.4x | Moderate |
RR's net debt is about 2.4 years of its operating earnings (EBITDA).
CAT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.7 | Neutral |
| Stochastic | 6.7 | Oversold |
CAT's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
RR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 26.4 | Oversold |
| Stochastic | 3.6 | Oversold |
RR's weekly RSI is 26 (oversold) and its Stochastic is 4 (oversold).
CAT PE vs Industrials Sector
| Metric | CAT | Sector median | Relative |
|---|---|---|---|
| PE | 24x | 24x | 1.1% below |
| PE % | 69 | 58 | 11 pts above |
CAT is trading at 24x earnings, in line with the Industrials sector's median of 24x.
RR PE vs Industrials Sector
RR has no meaningful PE right now: it lost money over the past year.
CAT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $709.0 | 15% below |
| 20 week MA | $797.0 | 24% below |
| 50 week MA | $771.3 | 22% below |
| 100 week MA | $586.7 | 3.2% above |
| 200 week MA | $443.1 | 37% above |
CAT has stronger trend alignment. CAT is above 2 of 5 weekly averages versus RR above 0 of 4.
RR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.27 | 35% below |
| 20 week MA | $1.52 | 46% below |
| 50 week MA | $2.32 | 65% below |
| 100 week MA | $2.56 | 68% below |
RR is in a downtrend: it's below all four of its weekly moving averages, and 68% below its 100-week average.
CAT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $148.3 | $179.6 | +21% |
| 2021 | $179.6 | $206.2 | +15% |
| 2022 | $206.2 | $239.9 | +16% |
| 2023 | $239.9 | $295.7 | +23% |
| 2024 | $295.7 | $364.9 | +23% |
| 2025 | $364.9 | $583.0 | +60% |
| 2026 YTD | $583.0 | $605.3 | +3.8% |
CAT has the edge over RR on returns for 2026, with the stronger performance.
RR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2023 | $5.25 | $5.95 | +13% |
| 2024 | $5.95 | $2.90 | -51% |
| 2025 | $2.90 | $3.36 | +16% |
| 2026 YTD | $3.36 | $0.82 | -76% |
RR is down 76% so far in 2026, after finishing higher in two of the previous three years.